stockrowHumana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.2%
- EPS
- +27.9%
- Free cash flow
- +58.5%
- Total debt
- +13.2%
Quarter to June 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) EPS (diluted)
Humana Inc.'s EPS (diluted) for fiscal 2025 was $9.84, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $10.57. Over the past ten years it has ranged from $4.07 (fiscal 2016) to $25.31 (fiscal 2020); the current reading is higher than 27% of that period. EPS (diluted) has fallen for 5 consecutive fiscal years. Humana Inc. ranks 4th of 12 Healthcare Plans companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $9.84 | (1.40%) |
| FY2024 | $9.98 | (50.10%) |
| FY2023 | $20.00 | (9.42%) |
| FY2022 | $22.08 | (2.60%) |
| FY2021 | $22.67 | (10.43%) |
| FY2020 | $25.31 | 25.92% |
| FY2019 | $20.10 | 65.30% |
| FY2018 | $12.16 | (27.66%) |
| FY2017 | $16.81 | 313.02% |
| FY2016 | $4.07 | (51.78%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $5.73 | (41.71%) |
| Mar 2026 | $9.83 | — |
| Dec 2025 | −$6.61 | — |
| Sep 2025 | $1.62 | (64.08%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| CI Cigna Group compare | $24.17 |
| ELV Elevance Health, Inc. compare | $23.45 |
| UNH UnitedHealth Group Incorporated compare | $17.51 |
| HUM Humana Inc. | $10.57 |
| CVS CVS Health Corporation compare | $3.78 |
| CNC Centene Corporation compare | $2.93 |
| OSCR Oscar Health, Inc. compare | $1.40 |
| CLOV Clover Health Investments, Corp. compare | −$0.05 |
| MOH Molina Healthcare, Inc compare | −$0.96 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on HUM
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement